☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hyperkalemia
AstraZeneca's Lokelma Receives CHMP's Recommendation for Approval for Patients with Hyperkalemia on Stable Hemodialysis
March 31, 2020
AstraZeneca's Lokelma (sodium zirconium cyclosilicate) Receives MHLW's Approval for the Treatment of Hyperkalemia in Japan
March 26, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
